Phenolic chalcones as agents against Trichomonas vaginalis.

Aldol condensation Antiprotozoal Galleria mellonella Molecular docking Purine nucleoside phosphorylase Reactive oxygen species Trichomoniasis

Journal

Bioorganic chemistry
ISSN: 1090-2120
Titre abrégé: Bioorg Chem
Pays: United States
ID NLM: 1303703

Informations de publication

Date de publication:
12 2023
Historique:
received: 27 12 2022
revised: 12 09 2023
accepted: 25 09 2023
medline: 3 11 2023
pubmed: 16 10 2023
entrez: 15 10 2023
Statut: ppublish

Résumé

Trichomonas vaginalis, a flagellated and anaerobic protozoan, is a causative agent of trichomoniasis. This disease is among the world's most common non-viral sexually transmitted infection. A single class drug, nitroimidazoles, is currently available for the trichomoniasis treatment. However, resistant isolates have been identified from unsuccessfully treated patients. Thus, there is a great challenge for a discovery of innovative anti-T. vaginalis agents. As part of our ongoing search for antiprotozoal chalcones, we designed and synthesized a series of 21 phenolic chalcones, which were evaluated against T. vaginalis trophozoites. Structure-activity relationship indicated hydroxyl group plays a role key in antiprotozoal activity. 4'-Hydroxychalcone (4HC) was the most active compound (IC

Identifiants

pubmed: 37839143
pii: S0045-2068(23)00549-7
doi: 10.1016/j.bioorg.2023.106888
pii:
doi:

Substances chimiques

4'-hydroxychalcone 2657-25-2
4-hydroxychalcone 20426-12-4
Chalcones 0
Reactive Oxygen Species 0
Antiprotozoal Agents 0
Phenols 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

106888

Informations de copyright

Copyright © 2023 Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Lígia R Oliveira (LR)

Institute of Biosciences, Humanities and Exact Sciences (Ibilce), São Paulo State University (Unesp), 15054-000 São José do Rio Preto, SP, Brazil.

Márcia R Trein (MR)

Faculty of Pharmacy, Federal University of Rio Grande do Sul, 90610-000 Porto Alegre, RS, Brazil.

Letícia R Assis (LR)

Institute of Biosciences, Humanities and Exact Sciences (Ibilce), São Paulo State University (Unesp), 15054-000 São José do Rio Preto, SP, Brazil.

Graziela V Rigo (GV)

Faculty of Pharmacy, Federal University of Rio Grande do Sul, 90610-000 Porto Alegre, RS, Brazil.

Leonardo P M Simões (LPM)

Institute of Chemistry, São Paulo State University (Unesp), Rua Professor Francisco Degni, 55, Jardim Quitandinha, Araraquara 14800-060, SP, Brazil.

Victor S Batista (VS)

Institute of Chemistry, São Paulo State University (Unesp), Rua Professor Francisco Degni, 55, Jardim Quitandinha, Araraquara 14800-060, SP, Brazil.

Alexandre J Macedo (AJ)

Faculty of Pharmacy, Federal University of Rio Grande do Sul, 90610-000 Porto Alegre, RS, Brazil.

Danielle S Trentin (DS)

Department of Basic Health Sciences, Federal University of Health Sciences of Porto Alegre, 90050-170 Porto Alegre, RS, Brazil.

Nailton M Nascimento-Júnior (NM)

Institute of Chemistry, São Paulo State University (Unesp), Rua Professor Francisco Degni, 55, Jardim Quitandinha, Araraquara 14800-060, SP, Brazil.

Tiana Tasca (T)

Faculty of Pharmacy, Federal University of Rio Grande do Sul, 90610-000 Porto Alegre, RS, Brazil. Electronic address: tiana.tasca@ufrgs.br.

Luis O Regasini (LO)

Institute of Biosciences, Humanities and Exact Sciences (Ibilce), São Paulo State University (Unesp), 15054-000 São José do Rio Preto, SP, Brazil. Electronic address: luis.regasini@unesp.br.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH